Selected research
Industry Research
Radiation Toxicity Therapeutics Industry Research Report 2026
Market perspective
The global Radiation Toxicity Therapeutics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Radiation Toxicity Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Radiation Toxicity Therapeutics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Radiation Toxicity Therapeutics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Radiation Toxicity Therapeutics include Coherus BioSciences, Jubilant Life Sciences, Mission Pharmacal Company, Partner Therapeutics, Recipharm AB, Siegfried Holdings, Viatris, Amgen and Novartis. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Radiation Toxicity Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Radiation Toxicity Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Radiation Toxicity Therapeutics Market by Company
Coherus BioSciences
Jubilant Life Sciences
Mission Pharmacal Company
Partner Therapeutics
Recipharm AB
Siegfried Holdings
Viatris
Amgen
Novartis
Radiation Toxicity Therapeutics Segment by Type
Ionizing Radiation
Non-ionizing Radiation
Radiation Toxicity Therapeutics Segment by Application
Hospital
Research & Academic Institutes
Radiation Toxicity Therapeutics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Toxicity Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiation Toxicity Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Toxicity Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Radiation Toxicity Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ionizing Radiation
- Non-ionizing Radiation
Applications
- Hospital
- Research & Academic Institutes
Companies covered
- Coherus BioSciences
- Jubilant Life Sciences
- Mission Pharmacal Company
- Partner Therapeutics
- Recipharm AB
- Siegfried Holdings
- Viatris
- Amgen
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Radiation Toxicity Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ionizing Radiation
- 2.2.3 Non-ionizing Radiation
- 2.3 Radiation Toxicity Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Research & Academic Institutes
- 2.4 Assumptions and Limitations
3 Radiation Toxicity Therapeutics Breakdown Data by Type
- 3.1 Global Radiation Toxicity Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Radiation Toxicity Therapeutics Forecasted Market Size by Type (2027-2032)
4 Radiation Toxicity Therapeutics Breakdown Data by Application
- 4.1 Global Radiation Toxicity Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Radiation Toxicity Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Radiation Toxicity Therapeutics Market Perspective (2021-2032)
- 5.2 Global Radiation Toxicity Therapeutics Growth Trends by Region
- 5.2.1 Global Radiation Toxicity Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Radiation Toxicity Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Radiation Toxicity Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Radiation Toxicity Therapeutics Market Dynamics
- 5.3.1 Radiation Toxicity Therapeutics Industry Trends
- 5.3.2 Radiation Toxicity Therapeutics Market Drivers
- 5.3.3 Radiation Toxicity Therapeutics Market Challenges
- 5.3.4 Radiation Toxicity Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Radiation Toxicity Therapeutics Players by Revenue
- 6.1.1 Global Top Radiation Toxicity Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Radiation Toxicity Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Radiation Toxicity Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Radiation Toxicity Therapeutics Head Office and Area Served
- 6.4 Global Radiation Toxicity Therapeutics Players, Product Type & Application
- 6.5 Global Radiation Toxicity Therapeutics Manufacturers Established Date
- 6.6 Global Radiation Toxicity Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Radiation Toxicity Therapeutics Market Size (2021-2032)
- 7.2 North America Radiation Toxicity Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Radiation Toxicity Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Radiation Toxicity Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Radiation Toxicity Therapeutics Market Size (2021-2032)
- 8.2 Europe Radiation Toxicity Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Radiation Toxicity Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Radiation Toxicity Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Radiation Toxicity Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Radiation Toxicity Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Radiation Toxicity Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Radiation Toxicity Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Radiation Toxicity Therapeutics Market Size (2021-2032)
- 10.2 South America Radiation Toxicity Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Radiation Toxicity Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Radiation Toxicity Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Radiation Toxicity Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Radiation Toxicity Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Radiation Toxicity Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Radiation Toxicity Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Coherus BioSciences
- 12.1.1 Coherus BioSciences Company Information
- 12.1.2 Coherus BioSciences Business Overview
- 12.1.3 Coherus BioSciences Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.1.4 Coherus BioSciences Radiation Toxicity Therapeutics Product Portfolio
- 12.1.5 Coherus BioSciences Recent Developments
- 12.2 Jubilant Life Sciences
- 12.2.1 Jubilant Life Sciences Company Information
- 12.2.2 Jubilant Life Sciences Business Overview
- 12.2.3 Jubilant Life Sciences Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.2.4 Jubilant Life Sciences Radiation Toxicity Therapeutics Product Portfolio
- 12.2.5 Jubilant Life Sciences Recent Developments
- 12.3 Mission Pharmacal Company
- 12.3.1 Mission Pharmacal Company Company Information
- 12.3.2 Mission Pharmacal Company Business Overview
- 12.3.3 Mission Pharmacal Company Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.3.4 Mission Pharmacal Company Radiation Toxicity Therapeutics Product Portfolio
- 12.3.5 Mission Pharmacal Company Recent Developments
- 12.4 Partner Therapeutics
- 12.4.1 Partner Therapeutics Company Information
- 12.4.2 Partner Therapeutics Business Overview
- 12.4.3 Partner Therapeutics Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.4.4 Partner Therapeutics Radiation Toxicity Therapeutics Product Portfolio
- 12.4.5 Partner Therapeutics Recent Developments
- 12.5 Recipharm AB
- 12.5.1 Recipharm AB Company Information
- 12.5.2 Recipharm AB Business Overview
- 12.5.3 Recipharm AB Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.5.4 Recipharm AB Radiation Toxicity Therapeutics Product Portfolio
- 12.5.5 Recipharm AB Recent Developments
- 12.6 Siegfried Holdings
- 12.6.1 Siegfried Holdings Company Information
- 12.6.2 Siegfried Holdings Business Overview
- 12.6.3 Siegfried Holdings Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.6.4 Siegfried Holdings Radiation Toxicity Therapeutics Product Portfolio
- 12.6.5 Siegfried Holdings Recent Developments
- 12.7 Viatris
- 12.7.1 Viatris Company Information
- 12.7.2 Viatris Business Overview
- 12.7.3 Viatris Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.7.4 Viatris Radiation Toxicity Therapeutics Product Portfolio
- 12.7.5 Viatris Recent Developments
- 12.8 Amgen
- 12.8.1 Amgen Company Information
- 12.8.2 Amgen Business Overview
- 12.8.3 Amgen Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.8.4 Amgen Radiation Toxicity Therapeutics Product Portfolio
- 12.8.5 Amgen Recent Developments
- 12.9 Novartis
- 12.9.1 Novartis Company Information
- 12.9.2 Novartis Business Overview
- 12.9.3 Novartis Revenue in Radiation Toxicity Therapeutics Business (2021-2026)
- 12.9.4 Novartis Radiation Toxicity Therapeutics Product Portfolio
- 12.9.5 Novartis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst